Effectiveness of acceptance and commitment therapy for inpatients with psychosis: Implementation feasibility and acceptability from a pilot randomized controlled trial
Schizophrenia Research · 2023
DOI: 10.1016/j.schres.2023.09.017 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Schizophrenia Research, 2023. Verfasst von Brandon A Gaudiano und 4 weiteren Autor:innen. Beteiligte Einrichtung: Alpert Medical School of Brown University, United States of America; Butler Hospital, United States of America; Providence VA Medical Center, United …. Hauptthemen laut MEDLINE: Acceptance and Commitment Therapy, Psychotic Disorders. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
OBJECTIVE: Acceptance and Commitment Therapy for Inpatients (ACT-IN) with psychosis has been found to be efficacious in previous trials, but its effectiveness has not been studied when implemented by frontline clinicians in routine settings. METHOD: In this pilot randomized controlled effectiveness trial, inpatients with schizophrenia-spectrum disorders were randomized to ACT-IN plus treatment as usual (TAU) (n = 23) or a time/attention matched (TAM) supportive condition plus TAU (n = 23) delivered by routine hospital staff. Both conditions received individual and group therapy during inpatient care and completed follow-up phone sessions during the first month post-discharge. Patients were assessed through 4 months post-discharge (blinded to condition) to determine feasibility, acceptability, and preliminary effectiveness of ACT-IN. RESULTS: ACT-IN was feasible to deliver with fidelity by frontline staff when integrated into an acute care setting. At post-treatment, patients reported significantly greater treatment satisfaction in ACT-IN relative to TAM. Overall, results showed significant but similar improvements for both conditions through 4-month follow-up in psychiatric symptoms, functioning, and mindfulness. Only ACT-IN improved over time in distress. Furthermore, patients receiving TAM had a 3.76 times greater risk of rehospitalization over 4 months compared with ACT-IN. CONCLUSIONS: ACT-IN is feasible and acceptable for patients with psychosis, can be implemented by hospital staff when integrated into acute treatment, and may result in decreased rehospitalization compared to alternative therapies. A future full-scale randomized-controlled implementation trial is warranted. CLINICALTRIALS: gov Identifer: NCT02336581.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Alpert Medical School of Brown University, United States of America; Butler Hospital, United States of America; Providence VA Medical Center, United States of America. Electronic address: Brandon_Gaudiano@brown.edu.
- SUNY Upstate Medical Center, United States of America.
- Michigan State University, United States of America.
- Boston University, United States of America.
- Alpert Medical School of Brown University, United States of America; Butler Hospital, United States of America.
Förderung
- NIMH NIH HHS
- National Institutes of Health
Zitieren
APA
Gaudiano, B. A., Ellenberg, S., Johnson, J. E., Mueser, K. T., & Miller, I. W. (2023). Effectiveness of acceptance and commitment therapy for inpatients with psychosis: Implementation feasibility and acceptability from a pilot randomized controlled trial. Schizophrenia Research. https://doi.org/10.1016/j.schres.2023.09.017
Vancouver
Gaudiano BA, Ellenberg S, Johnson JE, Mueser KT, Miller IW. Effectiveness of acceptance and commitment therapy for inpatients with psychosis: Implementation feasibility and acceptability from a pilot randomized controlled trial. Schizophrenia Research. 2023. doi:10.1016/j.schres.2023.09.017
BibTeX
@article{Gaudiano2023,
author = {Gaudiano, Brandon A and Ellenberg, Stacy and Johnson, Jennifer E and Mueser, Kim T and Miller, Ivan W},
title = {Effectiveness of acceptance and commitment therapy for inpatients with psychosis: Implementation feasibility and acceptability from a pilot randomized controlled trial},
journal = {Schizophrenia Research},
year = {2023},
doi = {10.1016/j.schres.2023.09.017}
}
EUVIMED